Deep Scientific Experience,
Global Industry Pedigree.

We bring decades of experience in biotechnology, with a proven track record of developing FDA-approved therapies at global leaders such as Novartis, Pfizer, Bayer, and Amgen. Our team combines deep research and development expertise from leading academic medical centers with specialized knowledge in oncology, hematology, and advanced gene and cell therapy. Together, we are committed to driving innovation that transforms patient care.

Featured
Mohan Rao, Ph.D.
Board of Directors, Management Team
Executive Chairman
Mohan Rao, Ph.D.
Board of Directors, Management Team
Executive Chairman

Dr. Rao is a pharmaceutical economist, entrepreneur, and CEO of Epsilon Life Sciences, with deep expertise in biotech company building and strategic value creation.

Board of Directors, Management Team
Executive Chairman
David Townson, Ph.D.
Management Team, Board of Directors
Chief Executive Officer
David Townson, Ph.D.
Management Team, Board of Directors
Chief Executive Officer

Dr. Townson is an executive bringing three decades of oncology and cell therapy leadership from Bayer, Novartis, and Pfizer.

Management Team, Board of Directors
Chief Executive Officer
John S. Lollar III, M.D.
Management Team
Chief Medical Officer
John S. Lollar III, M.D.
Management Team
Chief Medical Officer

Dr. Lollar is a hematologist and Hemophilia of Georgia Professor of Pediatrics at Emory University. He also invented Obizur, a commercialized Factor VIII recombinant.

Management Team
Chief Medical Officer
Kimberly Grove
Management Team
Chief Financial Officer
Kimberly Grove
Management Team
Chief Financial Officer

Ms. Grove has 20+ years of finance & accounting experience at Navigant Consulting, Inc., an NYSE-listed public company, and at Epsilon Life Sciences.

Management Team
Chief Financial Officer
Chris Doering, Ph.D.
Management Team
Chief Scientific Officer
Chris Doering, Ph.D.
Management Team
Chief Scientific Officer

Dr. Doering is a Professor of Pediatrics at Emory Medical School, leading drug discovery programs on gene and protein engineering.​

Management Team
Chief Scientific Officer
Tom Abshire, M.D.
Scientific Advisory Board
Medical College of Wisconsin
Tom Abshire, M.D.
Scientific Advisory Board
Medical College of Wisconsin

Dr. Abshire is a hematologist-oncologist, recognized for pioneering research in bleeding disorders and childhood Leukemia.

Scientific Advisory Board
Medical College of Wisconsin
Kimberly Nearing
Management Team
Chief Business Officer
Kimberly Nearing
Management Team
Chief Business Officer

Ms. Nearing has 20+ years of biotech experience in investment banking, venture capital, and senior industry roles at Amgen & IBM Healthcare, driving strategic partnerships and commercial growth.

Management Team
Chief Business Officer
William Swaney
Management Team
Chief Manufacturing Officer
William Swaney
Management Team
Chief Manufacturing Officer

Mr. Swaney has 25+ years of GMP experience manufacturing 100+ viral vectors and cellular products, including pioneering gene therapies such as CARVYKTI®.

Management Team
Chief Manufacturing Officer
Paul Ness, M.D.
Scientific Advisory Board
Johns Hopkins University
Paul Ness, M.D.
Scientific Advisory Board
Johns Hopkins University

Dr. Ness is an expert in transfusion medicine, hematology, and oncology at Johns Hopkins University, with decades of clinical and research leadership in blood disorders and cellular therapies.

Scientific Advisory Board
Johns Hopkins University
Nigel Key, M.D.
Scientific Advisory Board
University of North Carolina
Nigel Key, M.D.
Scientific Advisory Board
University of North Carolina

Dr. Key is a hematologist, a Professor of Medicine at University of North Carolina at Chapel Hill (UNC), and Director of the UNC Blood Research Center.

Scientific Advisory Board
University of North Carolina
Po Ear, Ph.D.
Scientific Advisory Board
Emory University
Po Ear, Ph.D.
Scientific Advisory Board
Emory University

Dr. Ear is an Associate Professor at the Winship Cancer Institute of Emory University, specializing in neuroendocrine tumors and cancer metabolism.

Scientific Advisory Board
Emory University
Dan Halperin, M.D.
Scientific Advisory Board
Emory University
Dan Halperin, M.D.
Scientific Advisory Board
Emory University

Dr. Halperin is a medical oncologist at Emory University specializing in neuroendocrine tumors and gastro-intestinal cancers, with extensive clinical trial experience.

Scientific Advisory Board
Emory University
James Baker
Board of Directors
Independent Director
James Baker
Board of Directors
Independent Director

Jim Baker is a managing partner and co-head for Kayne Anderson’s energy infrastructure strategies, responsible for overseeing the group’s investment strategies. Baker serves as chairman of the board, president and CEO of KYN.

Board of Directors
Independent Director